Hepatic encephalopathy significantly increased AKI risk, while higher albumin levels reduced it. Treatment with PPI/H2 blockers or kanamycin/rifaximin was associated with a reduced risk of AKI development. The gene discussed is ALB; the disease is acute kidney injury.